Read + Share
Amedeo Smart
Independent Medical Education
Liu Y, Gao GF, Minna JD, Williams NS, et al. Loss of wild type KRAS in KRAS(MUT) lung adenocarcinoma is associated with cancer mortality and confers sensitivity to FASN inhibitors. Lung Cancer 2021;153:73-80.PMID: 33465697
Email
LinkedIn
Facebook
Twitter
Privacy Policy